Corrigendum to “Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells” [Biochem. Pharmacol. 176 (2020) 113902] (Biochemical Pharmacology (2020) 176, (S0006295220301301), (10.1016/j.bcp.2020.113902))